Journal
RAPID COMMUNICATIONS IN MASS SPECTROMETRY
Volume 21, Issue 22, Pages 3593-3607Publisher
JOHN WILEY & SONS LTD
DOI: 10.1002/rcm.2832
Keywords
-
Funding
- NCI NIH HHS [CA63477] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [R01CA063477, U01CA063477] Funding Source: NIH RePORTER
Ask authors/readers for more resources
PHY906 is a Chinese medicine formulation prepared from four medicinal herbs for adjuvant cancer chemotherapy. In this paper, liquid chromatography/electrospray ionization time-of-flight mass spectrometry (LC/ESI-TOFMS) was used to clarify the chemical composition of PHY906. The aqueous extract of PHY906 was separated on a Waters Atlantis C-18 column, and was eluted with acetonitrile/0.05% (v/v) formic acid. The separated compounds were identified with pure standards, or tentatively characterized by analyzing their mass spectra recorded in both negative and positive ion polarity modes. Further structural information was obtained from in-source fragmentation. Based on the LC/MS analysis, we proposed the structures for 64 bioactive compounds, including flavonoids, triterpene saponins, and monoterpene glycosides. All the compounds identified from PHY906 were further assigned in the four individual herbs, and some of them are reported for the first time. Copyright (C) 2007 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available